- bioMerieux
- Overview
- Last Modified:
- June 3, 2025
- Company type:
- Public
- Industry:
- Biotechnology
- Verified:
- No
- No of Employees:
- 10 001 - 50 000
- Stock Code:
- BIM
- Download
- Signed Health Status Declaration Form
- Turnover $50m + ?:
- Yes
- Headquarters:
- Marcy-l'Étoile, France, Rhône, France
- Public Interest Score:
- 750+
- bioMerieux
- General Information
Description
A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide.
Since 1963, we’ve been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place.
The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Jean-Luc Belingard:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Marie-Hélène Habert-Dassault:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Philippe Archinard:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Boel Harold:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Fanny Letier:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Marie-Paule Kieny:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Viviane Monges:
qone: No, qtwo: No, qthree: No, qfour: No, qfive: No, qsix: No
Subsribe/ Login to view details on company risk rating
5 Benchmark > 4 Excellent > 3Â Good > 2 Caution > 1 Risk
- Company Information
- Company System Number:
- 14871
- Founded Year:
- 1963
- Registration Number:
- 2007/024149/07
- Country:
- France
- Stock Exchanges:
-
- Euronext Paris Exchange
- Financial year end:
- December
- No. of Countries operations:
- 45
- Company Status:
- In Business
- Industry Sub Category:
- Date listed on Stock Exchange:
- 30/06/2014
- Contact Information
- Business operation:
- bioMérieux provides a large set of diagnostic solutions to diagnose and manage infections, and support physicians in the timely identification and management of organ failures, like acute myocardial infarction, heart failure, pulmonary embolism and acute kidney injury (AKI).
- Primary office:
- Marcy-l'Étoile, France
- Additional Information
- Listed?:
- Yes
- Company secretary:
- Gary Mills
- Reporting currency:
- EUR
- ISIN number (12 digit):
EPA
FR0013280286- Authorised shares:
- 119 270 000
- Issued shares:
- 117 750 000
- No of shareholders:
- 1001 and more shareholders
- No of shareholders holding 20%:
- 1 shareholder
- Number of shares traded
- Per Year:
- Per Quarter:
- Per Month:
Shareholders holding 5% +
For a comprehensive list, please contact InsidEntity.
Material Subsidiaries/Associates
For a comprehensive list, please contact InsidEntity.
Countries Operations/ Offices
Company Directors
Alexandre
Non ExecutiveMarie-Hélène
Non ExecutivePhilippe
Non ExecutiveBoel
Non ExecutiveMarie-Paule
Non ExecutiveViviane
Non Executive
Directors Tenure
Director Experience
Company Auditors
Ernst & Young
Company Past Directors
Sylvain
Company Committees
|
Committee
|
Abbreviation
|
|---|---|
|
Supervisory Board
|
SB
|
|
Board
|
BD
|
|
Risk & Compliance
|
RC
|
|
Audit
|
AU
|
|
Remuneration
|
RE
|
|
Capital investment
|
CI
|
|
Industry Specific
|
IS
|
|
Nominations & Governance
|
NG
|
|
Health, Safety & Environment
|
HS
|
|
Social & Ethics
|
SE
|
|
Technology
|
TE
|
|
Executive
|
EX
|
|
Other
|
OT
|
